# Influence of BCG on TDaP-IPV Vaccination

> **NCT02771782** · PHASE4 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 75 (estimated)

## Conditions studied

- Whooping Cough

## Interventions

- **BIOLOGICAL:** BCG vaccine (SSI)
- **BIOLOGICAL:** TDaP-IPV vaccine

## Key facts

- **NCT ID:** NCT02771782
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-07
- **Final completion:** 2017-04
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2016-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02771782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02771782, "Influence of BCG on TDaP-IPV Vaccination". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02771782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*